This document is a corrigendum issued by the National Pharmaceutical Pricing Authority (NPPA), Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Government of India, dated April 6, 2017. It amends Order No. S.O. 1040(E) dated April 1, 2017, which pertains to the revision of ceiling prices for 68 formulations based on the Wholesale Price Index (WPI). The corrigendum specifically revises the entries at Sl. No. 27, 28, and 59 in the table of the original order, both in Hindi and English versions.
Specifically, the changes are as follows:
* **Sl. No. 27:** Replaces "Filgrastim Injection" with "Rifampicin Tablet," changing the strength from "1 ML" to "150mg," and revising the ceiling price from Rs. 2,347.16 to Rs. 1.53 per tablet (Unit).
* **Sl. No. 28:** Replaces "Fluoxetine Hydrochloride Capsules" with "Rifampicin Tablet," changing the strength from "20 mg" to "450mg," and revising the ceiling price from Rs. 3.80 to Rs. 4.19 per tablet (Unit).
* **Sl. No. 59:** Replaces "Prednisolone Injection" with "Fluconazole Capsule," changing the strength from "20mg" to "150 mg," and revising the ceiling price from Rs. 4.65 to Rs. 25.84 per capsule (Unit).
The corrigendum clarifies that all other notes and contents mentioned in the original order (S.O. 1040(E) dated April 1, 2017) remain unchanged.
The file number for this corrigendum is PN175432017F.No. 8432017D.P.NPPADiv.II. The issuing authority is Prasenjit Das, Assistant Director, NPPA.
Key Entities Referenced
National Pharmaceutical Pricing Authority: A regulatory agency in India that fixes and revises prices of pharmaceutical products.
Ministry of Chemicals and Fertilizers: The Indian government ministry responsible for policy formulation and regulation of the chemical and fertilizer industries.
Department of Pharmaceuticals: A department within the Ministry of Chemicals and Fertilizers, focusing on the pharmaceutical sector.
New Delhi: The location of the National Pharmaceutical Pricing Authority and the place of publication for the notification.
S.O. 1040E: An order number issued by the National Pharmaceutical Pricing Authority on April 1, 2017, relating to price revisions.
Wholesale Price Index (WPI): An index used as the basis for revising ceiling prices of 68 formulations.
Filgrastim Injection: A pharmaceutical product whose price is being revised.
Rifampicin Tablet: A pharmaceutical product whose price is being revised.
jftLVªh laö Mhö ,yö&33004@99
REGD. NO. D. L.-33004/99
vlk/kj.k
EXTRAORDINARY
Hkkx II—[k.M 3—mi&[k.M (ii)
PART II—Section 3—Sub-section (ii)
izkf/dkj ls izdkf'kr
PUBLISHED BY AUTHORITY
la- 964] ubZ fnYyh] c`gLifrokj] vizSy 6] 2017@pS=k 16] 1939
No. 964] NEW DELHI, THURSDAY, APRIL 6, 2017/CHAITRA 16, 1939
jlk;u vkSj moZjd ea=ky;
¼vkS’k/k foHkkx½
jk’Vªh; vkS’k/k ewY; fu/kkZj.k izkf/kdj.k
’kqf)&i=
ubZ fnYyh] 6 vizSy] 2017
dk- vk- 1090¼v½.—Hkkjr ds jkti=] vlk/kkj.k esa izdkf”kr jk’Vªh; vkS’k/k ewY; fu/kkZj.k izkf/kdj.k] ds fnukad 01
vizSy] 2017 ds vkns”k la0 dk0 vk0 1040 ¼v½ ¼tks Fkksd ewY; lwpdkda ds vk/kkj ij 68 fofufeZfr;ksa ds vf/kdre ewY;ksa ls
lacaf/kr gS½ esa dfFkr vkns”k ¼fganh vkSj vaxzsth laLdj.k nksuksa esa½ dh lkj.kh esa dz0 la0 27] 28 vkSj 59 ij izfof"V;ka fuEu
izdkj i<+h tk;sxh %
fuEu ds LFkku ij
Ø- vuqlwfpr fofufeZfr dk [kqjkd :i ,oa izcyrk bdkbZ vf/kdre dher ¼#-½
la- uke 1.4.2017 ls izHkkoh
¼1½ ¼2½ ¼3½ ¼4½ ¼5½
27 fQYxzkfLVe batsD”ku 1fefy- 2]347-16
28 ¶ykSDlSVkbu gkbMªksDyksjkbM dSIlwy 20 fexzk- 1 dSIlwy 3-80
izsMfulksyksu batsD”ku20fexzk-¼lksfM;e 1fefy- 4-65
59
QksLQsV ;k lfDlusV esa½
fuEu :Ik esa izfrLFkkfir fd;k tk,
Ø- vuqlwfpr fofufeZfr dk uke [kqjkd :i ,oa bdkbZ vf/kdre dher ¼#-½
la- izcyrk 1.4.2017 ls izHkkoh
¼1½ ¼2½ ¼3½ ¼4½ ¼5½
27 fjQkfEiflu Xkksyh 150 fexzk0 1 xksyh 1-53
1933 GI/2017 (1)2 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)]
28 fjQkfEiflu Xkksyh 450 fexzk0 1 xksyh 4-19
59 ¶yqdksuktksy dSIlwy 150 fexzk 1 dSIlwy 25-84
ewy vkns”k dk0 vk0 1040 ¼v½ fnukad 01 vizSYk] 2017 esa of.kZr lHkh fVIif.k;ka vkSj vU; fo’k; oLrq ogha jgsaxsA
[dka-la-@175@43@2017@Qk- la- 8¼43½@2017@Mh-ih-@,uihih,&fMoh-&II]
izlsuthr nkl] lgk;d funs”kd
MINISTRY OF CHEMICALS AND FERTILIZERS
(Department of Pharmaceuticals)
NATIONAL PHARMACEUTICAL PRICING AUTHORITY
CORRIGENDUM
New Delhi, the 6th April, 2017
S.O. 1090 (E).—In National Pharmaceutical Pricing Authority's Order No. S.O. 1040(E) dated the 1st
April 2017 (relating to the revision of ceiling prices of 68 formulations on the basis of Wholesale Price Index
(WPI)), published in the Gazette of India, Extraordinary ,the entries at Sl. No. 27, 28 and 59 in the Table of
the said order, both in Hindi & English version, shall be read as follows :
Instead of
Sl. No. Name of the Dosage form & Strength Unit Ceiling Price (Rs.)
Scheduled w.e.f 1.4.2017
Formulation
(1) (2) (3) (4) (5)
27 Filgrastim Injection 1 ML 2,347.16
28 Fluoxetine Capsules 20 mg 1 Capsule 3.80
hydrochloride
59 Prednisolone Injection 20mg (as 1 ML 4.65
Sodium Phosphate or
Succinct)
Read as
Sl. No. Name of the Scheduled Dosage form & Unit Ceiling Price (Rs.)
Formulation Strength w.e.f 1.4.2017
(1) (2) (3) (4) (5)
27 Rifampicin Tablet 150mg 1 Tablet 1.53
28 Rifampicin Tablet 450mg 1 Tablet 4.19
59 Fluconazole Capsule 150 mg 1 Capsule 25.84
All the notes and other contents mentioned in the original order original Order S.O. 1040(E) dated 1st April
2017 shall remain same.
[PN/175/43/2017/F.No. 8(43)/2017/D.P./NPPA-Div.-II]
PRASENJIT DAS, Assistant Director
Uploaded by Dte. of Printing at Government of India Press, Ring Road, Mayapuri, New Delhi-110064
and Published by the Controller of Publications, Delhi-110054.